Publication: Trends in the Management and Outcomes of Acute Pulmonary Embolism: Analysis From the RIETE Registry.
dc.contributor.author | Jiménez, David | |
dc.contributor.author | de Miguel-Díez, Javier | |
dc.contributor.author | Guijarro, Ricardo | |
dc.contributor.author | Trujillo-Santos, Javier | |
dc.contributor.author | Otero, Remedios | |
dc.contributor.author | Barba, Raquel | |
dc.contributor.author | Muriel, Alfonso | |
dc.contributor.author | Meyer, Guy | |
dc.contributor.author | Yusen, Roger D | |
dc.contributor.author | Monreal, Manuel | |
dc.contributor.author | RIETE Investigators | |
dc.date.accessioned | 2023-01-25T08:30:40Z | |
dc.date.available | 2023-01-25T08:30:40Z | |
dc.date.issued | 2016 | |
dc.description.abstract | Despite advances in hospital management in recent years, it is not clear whether mortality after acute pulmonary embolism (PE) has decreased over time. This study describes the trends in the management and outcomes of acute symptomatic PE. We identified adults with acute PE enrolled in the registry between 2001 and 2013. We assessed temporal trends in length of hospital stay and use of pharmacological and interventional therapies. Using multivariable regression, we examined temporal trends in risk-adjusted rates of all-cause and PE-related death to 30 days after diagnosis. Among 23,858 patients with PE, mean length of stay decreased from 13.6 to 9.3 days over time (32% relative reduction, p In a large international registry of patients with PE, improvements in length of stay and changes in the initial treatment were accompanied by a reduction in short-term all-cause and PE-specific mortality. | |
dc.identifier.doi | 10.1016/j.jacc.2015.10.060 | |
dc.identifier.essn | 1558-3597 | |
dc.identifier.pmid | 26791063 | |
dc.identifier.unpaywallURL | https://doi.org/10.1016/j.jacc.2015.10.060 | |
dc.identifier.uri | http://hdl.handle.net/10668/9754 | |
dc.issue.number | 2 | |
dc.journal.title | Journal of the American College of Cardiology | |
dc.journal.titleabbreviation | J Am Coll Cardiol | |
dc.language.iso | en | |
dc.organization | Instituto de Investigación Biomédica de Málaga-IBIMA | |
dc.organization | Hospital Universitario Regional de Málaga | |
dc.organization | Instituto de Biomedicina de Sevilla-IBIS | |
dc.organization | Hospital Universitario Virgen del Rocío | |
dc.page.number | 162-170 | |
dc.pubmedtype | Journal Article | |
dc.pubmedtype | Research Support, Non-U.S. Gov't | |
dc.rights.accessRights | open access | |
dc.subject | heparin | |
dc.subject | length of stay | |
dc.subject | outcomes | |
dc.subject | prognosis | |
dc.subject | surgical embolectomy | |
dc.subject | survival | |
dc.subject | thrombolysis | |
dc.subject.mesh | Acute Disease | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Aged, 80 and over | |
dc.subject.mesh | Disease Management | |
dc.subject.mesh | Female | |
dc.subject.mesh | Fibrinolytic Agents | |
dc.subject.mesh | Heparin, Low-Molecular-Weight | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Length of Stay | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Outcome and Process Assessment, Health Care | |
dc.subject.mesh | Prognosis | |
dc.subject.mesh | Pulmonary Embolism | |
dc.subject.mesh | Risk Assessment | |
dc.subject.mesh | Spain | |
dc.subject.mesh | Survival Analysis | |
dc.subject.mesh | Thrombectomy | |
dc.subject.mesh | Thrombolytic Therapy | |
dc.title | Trends in the Management and Outcomes of Acute Pulmonary Embolism: Analysis From the RIETE Registry. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 67 | |
dspace.entity.type | Publication |